Ress Life Investments A/S
6.7.2026 19:24:15 CEST | Globenewswire | Press release
Major shareholder announcement pursuant to section 30 of the Capital Markets Act.
Major shareholder announcement pursuant to section 30 of the Capital Markets Act.
Ress Life Investments A/S
Nybrogade 12
DK-1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 6 July 2026
Corporate Announcement 24/2026
Major shareholder announcement pursuant to section 30 of the Capital Markets Act.
Ress Life Investments A/S has received notification that Longevity Strategy Fund A/S, holds more than 5% of the share capital and voting rights in Ress Life Investments A/S. On 30 June 2026, Longevity Strategy Fund A/S has purchased shares in Ress Life Investments A/S and therefore now holds 8,119 shares in Ress Life Investments A/S with a total nominal value of EUR 4,059,500 corresponding to 6.83% of the total share capital and voting rights in Ress Life Investments A/S.
Questions related to this announcement can be made to the company’s AIF-manager, Finserve Nordic AB.
Contact person:
Gustaf Hagerud
gustaf.hagerud@finserve.se
Tel + 46 73 660 72 42
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Cosmos Health Inc.6.7.2026 20:30:00 CEST | Press release
Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases
Genmab A/S6.7.2026 19:58:46 CEST | Press release
Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
Biotalys NV6.7.2026 18:00:00 CEST | Press release
Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights
Vastned NV6.7.2026 18:00:00 CEST | Press release
Disclosure of transparency notification (article 14, first paragraph, of the Law of 2 May 2007)
Zealand Pharma6.7.2026 17:00:00 CEST | Press release
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom